To ask the Secretary of State for Health and Social Care, whether he plans to write off the £ 370 million advance payments provided to community pharmacy owners to cover costs incurred during the covid-19 outbreak.
25 March 2021
Discussions are ongoing with the Pharmaceutical Services Negotiating Committee about additional funding for costs incurred during the COVID-19 pandemic. As part of its ongoing assessment of COVID-19 costs incurred by the sector, the Government will take account of the £370 million increased advance payments paid to community pharmacies
The COVID-19 support package for community pharmacy also included general COVID-19 business financial support, funding for Bank Holiday openings, social distancing measures and the medicine delivery service to shielded patients and free personal protective equipment, as well as non-monetary support, including the removal of some administrative tasks, flexibility in opening hours and the delayed introduction of new services.